Physician profile
Arpeta Gupta
NPI 1760624688
$31,869.98
in general payments reported to CMS, 2019-2025
49 companies · $11K in 2025
The $11K reported for 2025 was more than what 90% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $60.00 · 2021: $701 · 2022: $2,462 · 2023: $2,806 · 2024: $15K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $14K · Food and Beverage: $8,605 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,850 · Travel and Lodging: $2,359 · Education: $64.65 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $13,710.00 |
| Food and Beverage | $8,604.83 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,850.00 |
| Travel and Lodging | $2,359.03 |
| Education | $64.65 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $21,387.57 | 2022-2025 | Korlym |
| Novo Nordisk INC | $1,307.35 | 2021-2025 | Rybelsus, Ozempic, Tresiba |
| Lilly USA, LLC | $816.05 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Abbott Laboratories | $747.05 | 2021-2025 | Freestyle Libre 3 |
| Amgen INC. | $744.97 | 2021-2025 | Evenity, Prolia, Tepezza |
| Sanofi-Aventis U.S. LLC | $649.19 | 2020-2025 | |
| Dexcom, INC. | $601.72 | 2021-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $573.64 | 2021-2024 | Afrezza |
| Radius Health, INC. | $531.28 | 2022-2024 | Tymlos |
| Insulet Corporation | $528.89 | 2022-2025 | Omnipod |
| Xeris Pharmaceuticals, INC. | $503.90 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $329.54 | 2021-2025 | |
| Abbvie INC. | $282.93 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $243.69 | 2021-2025 | Jardiance |
| Medtronic, INC. | $220.39 | 2022-2025 | Minimed 780g, Intellis Adaptivestim |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $219.48 | 2022-2025 | Xyosted, Nocdurna, Tlando |
| Tandem Diabetes Care, INC. | $217.76 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Cequr Corporation | $180.06 | 2024-2025 | Cequr Simplicity |
| Recordati_rare_diseases_inc. | $157.59 | 2024-2025 | Isturisa, Signifor Lar |
| Ascendis Pharma Endocrinology INC | $150.58 | 2023-2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $146.63 | 2023-2025 | Strensiq |
| Ibsa Pharma INC. | $136.66 | 2021-2025 | Tirosint, Flector, Licart |
| Neurocrine Biosciences, INC. | $129.05 | 2025 | |
| Ucb, INC. | $102.15 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $96.82 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $79.67 | 2022 | |
| Novartis Pharmaceuticals Corporation | $69.03 | 2024 | |
| Kyowa Kirin, INC. | $63.76 | 2025 | |
| Halozyme INC | $60.80 | 2023 | |
| Sequel Med Tech, LLC | $60.59 | 2025 | Twiist |
| Globus Medical, INC. | $57.13 | 2025 | Senza |
| Glaxosmithkline, LLC. | $53.80 | 2022 | |
| Amryt Pharma Holdings LTD | $52.59 | 2022-2023 | Myalept |
| Amneal Pharmaceuticals LLC | $33.87 | 2025 | Unithroid |
| Acella Pharmaceuticals, LLC | $31.69 | 2024-2025 | NP Thyroid 60 |
| Merck Sharp & Dohme LLC | $31.55 | 2021-2022 | |
| Astellas Pharma US INC | $30.31 | 2024 | Veozah |
| Rhythm Pharmaceuticals, INC. | $29.57 | 2025 | Imcivree |
| Horizon Therapeutics Plc | $28.52 | 2022 | |
| Beta Bionics, INC. | $24.71 | 2024 | Ilet Bionic Pancreas |
| Vivus LLC | $21.02 | 2024 | Qsymia |
| Ascensia Diabetes Care US INC. | $20.74 | 2023 | |
| Chiesi USA, INC. | $20.38 | 2025 | Mycapssa |
| Janssen Pharmaceuticals, INC | $18.89 | 2021 | |
| Tolmar, INC. | $18.67 | 2025 | Jatenzo |
| Pulse Biosciences, INC. | $17.57 | 2025 | Cellfx |
| Currax Pharmaceuticals LLC | $15.85 | 2025 | Contrave |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.50 | 2021 | |
| Janssen Biotech, INC. | $11.83 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arpeta Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.